Agios Pharmaceuticals (AGIO) Net Income Growth (5y) (2017 - 2026)
Agios Pharmaceuticals (AGIO) Net Income Growth (5y) (2017 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,132.22 Bn | 67,131.94 Bn | - |
| 2 | Nanobiotix | 1,910.87 Bn | 1,910.81 Bn | - |
| 3 | Akari Therapeutics | 989.71 Bn | 989.71 Bn | - |
| 4 | BeOne Medicines | 471.60 Bn | 466.80 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.71 Bn | 114.46 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.83 Bn | 61.07 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.74 Bn | 62.74 Bn | - |
| 8 | Argenx Se | 55.83 Bn | 50.65 Bn | 1.41 Bn |
| 9 | Alnylam Pharmaceuticals | 37.33 Bn | 34.32 Bn | 959.66 Mn |
| 10 | Agios Pharmaceuticals | 2.21 Bn | 1.47 Bn | 19.43 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -15.72% |
| Dec 31, 2025 | -52.46% |
| Sep 30, 2025 | -39.18% |
| Jun 30, 2025 | -71.16% |
| Mar 31, 2025 | -35.35% |
| Dec 31, 2024 | 1.98% |
| Sep 30, 2024 | 60.79% |
| Jun 30, 2024 | 0.46% |
| Mar 31, 2024 | -0.11% |
| Dec 31, 2023 | 27.61% |
| Sep 30, 2023 | 1.15% |
| Jun 30, 2023 | -4.81% |
| Mar 31, 2023 | 1.41% |
| Dec 31, 2021 | 15.04% |
| Sep 30, 2021 | 51.78% |
| Jun 30, 2021 | 51.62% |
| Mar 31, 2021 | 86.45% |
| Dec 31, 2020 | 20.24% |
| Sep 30, 2020 | 13.23% |
| Jun 30, 2020 | 52.28% |